Harte-Hanks HHS unveils its next round of earnings Thursday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement
Earnings and Revenue
Wall Street analysts see Harte-Hanks reporting earnings of 20 cents per share on revenue of $102 million.
Harte-Hanks reported a loss of 91 cents when it published results during the same quarter last year. Sales in that period totaled $110.1 million. If the company were to post earnings inline with the consensus estimate when it reports Thursday, sales would be down 7.36 percent on a year-over-year basis.
Harte-Hanks's reported EPS has stacked up against analyst estimates in the past like this:
Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
EPS Estimate | -0.07 | -0.01 | -0.01 | |
EPS Actual | -0.04 | -0.04 | -0.12 | -0.91 |
Stock Performance
Over the last 52-week period, shares are up 502.08 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. Analysts generally rate Harte-Hanks stock as Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Harte-Hanks's Q4 is scheduled to hold a conference call at 5:00 p.m. ET and it can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.